| A Study of HER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma Esophagogastric (NCT05315830) | The First Affiliated Hospital of Bengbu Medical University | 2022-03-07 |
| Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG (NCT04878783) | University of Roma La Sapienza | 2019-12-20 |
| EGFR-targeted Therapy for Gastric Cancer (NCT04077255) | National Cancer Center, Korea | 2019-09-01 |
| Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma (NCT03966118) | P. C. Thuss-Patience | 2019-04-01 |
| Regorafenib Combined With Irinotecan as Second-line in Patients With Metastatic Gastro-oesophageal Adenocarcinomas (NCT03722108) | UNICANCER | 2019-02-07 |
| Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial (NCT02678182) | Royal Marsden NHS Foundation Trust | 2015-02-01 |
| A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction (NCT02202759) | Millennium Pharmaceuticals, Inc. | 2014-08-04 |
| Early Oral Feeding After Total Gastrectomy for Cancer (NCT01962519) | Jagiellonian University | 2012-01-01 |
| Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach (NCT01472029) | AIO-Studien-gGmbH | 2011-12-01 |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors (NCT01233505) | National Cancer Institute (NCI) | 2010-10-01 |
| Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer (NCT01095120) | Genta Incorporated | 2010-03-01 |
| Pharmacokinetic Study of Capecitabine After Total Gastrectomy for Stomach Adenocarcinoma (NCT00871273) | Cambridge University Hospitals NHS Foundation Trust | 2009-11-01 |
| Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer (NCT00982592) | National Cancer Institute (NCI) | 2009-09-01 |
| Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer (NCT00607594) | National Cancer Institute (NCI) | 2008-01-01 |
| Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT01561014) | Wake Forest University Health Sciences | 2007-04-01 |
| Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (NCT01640782) | Mario Negri Institute for Pharmacological Research | 2005-02-01 |
| FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer (NCT00098527) | National Cancer Institute (NCI) | 2004-10-01 |